Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1999 1
2000 2
2001 1
2002 11
2003 8
2004 3
2005 4
2006 10
2007 7
2008 6
2009 10
2010 2
2011 6
2012 5
2013 4
2014 7
2015 2
2016 3
2018 5
2019 3
2020 1
2021 5
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19789626

107 results

Results by year

Filters applied: . Clear all
Page 1
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Dubreuil P, Letard S, Ciufolini M, Gros L, Humbert M, Castéran N, Borge L, Hajem B, Lermet A, Sippl W, Voisset E, Arock M, Auclair C, Leventhal PS, Mansfield CD, Moussy A, Hermine O. Dubreuil P, et al. PLoS One. 2009 Sep 30;4(9):e7258. doi: 10.1371/journal.pone.0007258. PLoS One. 2009. PMID: 19789626 Free PMC article.
An evaluation of masitinib for treating systemic mastocytosis.
Laforgia M, Marech I, Nardulli P, Calabrò C, Gadaleta CD, Ranieri G. Laforgia M, et al. Expert Opin Pharmacother. 2019 Sep;20(13):1539-1550. doi: 10.1080/14656566.2019.1645121. Epub 2019 Aug 5. Expert Opin Pharmacother. 2019. PMID: 31381378 Review.
Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family.
Brave SR, Ratcliffe K, Wilson Z, James NH, Ashton S, Wainwright A, Kendrew J, Dudley P, Broadbent N, Sproat G, Taylor S, Barnes C, Silva JC, Farnsworth CL, Hennequin L, Ogilvie DJ, Jürgensmeier JM, Shibuya M, Wedge SR, Barry ST. Brave SR, et al. Mol Cancer Ther. 2011 May;10(5):861-73. doi: 10.1158/1535-7163.MCT-10-0976. Epub 2011 Mar 25. Mol Cancer Ther. 2011. PMID: 21441409 Free article.
107 results